Skip to main content
Clinical Trials/NCT01117610
NCT01117610
Unknown
Phase 4

A Preemptive Epidural Ropivacaine for Postoperative Pain Relief in Degenerative Lumbar Spine Surgery: A Prospective Randomized Study

Chung-Ang University Hosptial, Chung-Ang University College of Medicine1 site in 1 country60 target enrollmentMay 2010

Overview

Phase
Phase 4
Intervention
Ropivacaine (epidural injection)
Conditions
Postoperative Pain
Sponsor
Chung-Ang University Hosptial, Chung-Ang University College of Medicine
Enrollment
60
Locations
1
Primary Endpoint
Visual analogue scale 4hour
Last Updated
16 years ago

Overview

Brief Summary

This prospective randomized study aims to evaluate the effectiveness of epidural injection of ropivacaine on the relief of pain in patients undergoing laminectomy.

Total 60 patients will be randomized into one of two groups (groupC or groupI) based on Excel number generation.

Patients in group C will receive no medication intraoperatively, and patients in group I will receive epidural injection of 0.1% ropivacaine 10ml before skin incision.

Visual analogue scale pain scores, fentanyl consumption and the frequency at which patients pushed the button (FPB) of a patient-controlled analgesia system will be recorded at 4,12,24,48 hour postoperatively.

Detailed Description

Patients in group I will receive 0.1% ropivacaine 10 ml before skin incision under guide of C-arm.

Registry
clinicaltrials.gov
Start Date
May 2010
End Date
April 2011
Last Updated
16 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Chung-Ang University Hosptial, Chung-Ang University College of Medicine

Eligibility Criteria

Inclusion Criteria

  • laminectomy

Exclusion Criteria

  • r/o infection
  • reoperation
  • mental change
  • allergy to local anesthetics

Arms & Interventions

epidural injection (group I)

patients in Group I will receive epidural injection of 0.1% ropivacaine 10 ml before skin incision.

Intervention: Ropivacaine (epidural injection)

epidural injection group (group C)

control group will receive no medication preoperatively and during operation

Intervention: Placebo (one of medication)

Outcomes

Primary Outcomes

Visual analogue scale 4hour

Time Frame: post op 4hour

Patients will be assessed for pain using a visual analogue pain scale (VAS). It is usually a horizontal line, 100 mm in length, anchored by word descriptors at each end; left side end which represents 0 is 'No pain', right side end with 100 is 'Very severe pain'. The patient marks on the line the point that they feel represents their perception of their current state. The VAS score is determined by measuring in millimeters from the left hand end of the line to the point that the patient marks. To check the severity of pain VAS will be measured at post op 4hour.

Secondary Outcomes

  • visual analogue scale 24hour(Post Op 24 hour)
  • visual analogue scale 12 hour(Post op 12 hour)
  • Visual analogue scale 48hour(Post Op 48hour)
  • Opioid consumption 4hour(Post Op 4hour)
  • Opioid consumption 24hour(Post op 24 hour)
  • Opioid consumption 12 hour(Post Op 12 hour)
  • Opioid consumption 48hour(Post Op 48 hour)
  • FPB 4 hour(Post Op 4 hour)
  • FPB 12 hour(post op 12 hour)
  • FPB 24 hour(Post Op 24 hour)
  • FPB 48 hour(Post Op 48 hour)

Study Sites (1)

Loading locations...

Similar Trials